|
KIAA0586 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.87730008894516E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.26389999869303E-08 |
| Normal-vs-Stage2 |
1.87536999999294E-05 |
| Normal-vs-Stage3 |
2.60939999607857E-08 |
| Normal-vs-Stage4 |
7.89020000446783E-08 |
| Stage1-vs-Stage2 |
5.449400E-01 |
| Stage1-vs-Stage3 |
2.869600E-01 |
| Stage1-vs-Stage4 |
1.794770E-01 |
| Stage2-vs-Stage3 |
8.749800E-01 |
| Stage2-vs-Stage4 |
5.709200E-01 |
| Stage3-vs-Stage4 |
6.151200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.28890001291649E-09 |
| Normal-vs-AfricanAmerican |
1.091510E-02 |
| Normal-vs-Asian |
2.29679999999011E-05 |
| Caucasian-vs-AfricanAmerican |
2.932200E-01 |
| Caucasian-vs-Asian |
9.244600E-01 |
| AfricanAmerican-vs-Asian |
3.857200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99109950749232E-10 |
| Normal-vs-Female |
3.21359999722048E-08 |
| Male-vs-Female |
8.043700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00830000004937E-06 |
| Normal-vs-Age(41-60Yrs) |
7.03110003552609E-09 |
| Normal-vs-Age(61-80Yrs) |
4.30330000522616E-08 |
| Normal-vs-Age(81-100Yrs) |
3.117200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.565000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.280400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.677800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.913400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.753000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.393600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.436000E-01 |
| Classical-VS-Follicular |
5.031100E-04 |
| Classical-VS-Other |
1.379840E-01 |
| Classical-VS-Normal |
6.17780000045087E-07 |
| Tall-VS-Follicular |
3.085800E-01 |
| Tall-VS-Other |
3.369000E-01 |
| Tall-VS-Normal |
4.45290000000709E-05 |
| Follicular-VS-Other |
7.699600E-01 |
| Follicular-VS-Normal |
1.09469999731715E-09 |
| Other-VS-Normal |
2.522100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.11539999248356E-09 |
| Normal-vs-N1 |
2.50439999960328E-07 |
| N0-vs-N1 |
4.740400E-01 |
|
|
